Virgin Pulse’s Pay-for-Performance Model for Digital Therapeutics

ARTICLE SUMMARY:

In January, Virgin Pulse acquired Blue Mesa Health, the developer of a digital program designed to reverse prediabetes, which affects one out of three people in the US.

Here at MedTech Strategist, we often discuss digital health as a paradigm that brings new kinds of players into health care, while requiring the development of new kinds of business models. Recently, an example of both came to our attention: the acquisition of digital therapeutic company Blue Mesa Health by Virgin Pulse, the largest employee health management company in terms of the number of customers and covered lives.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.


Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite

Questions?

We're here to help! Please contact us at: